392 related articles for article (PubMed ID: 33179140)
1. The regulatory roles of p53 in cardiovascular health and disease.
Men H; Cai H; Cheng Q; Zhou W; Wang X; Huang S; Zheng Y; Cai L
Cell Mol Life Sci; 2021 Mar; 78(5):2001-2018. PubMed ID: 33179140
[TBL] [Abstract][Full Text] [Related]
2. Activation of the
Sun Y; Wang Q; Fang Y; Wu C; Lu G; Chen Z
Dis Model Mech; 2017 Oct; 10(10):1217-1227. PubMed ID: 28801532
[TBL] [Abstract][Full Text] [Related]
3. p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs.
Stanley-Hasnain S; Hauck L; Grothe D; Aschar-Sobbi R; Beca S; Butany J; Backx PH; Mak TW; Billia F
Cell Cycle; 2017; 16(17):1585-1600. PubMed ID: 28745540
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor p53 and its mutants in cancer metabolism.
Liu J; Zhang C; Hu W; Feng Z
Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
[TBL] [Abstract][Full Text] [Related]
5. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
6. Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53.
Lieschke E; Wang Z; Kelly GL; Strasser A
J Mol Cell Biol; 2019 Mar; 11(3):212-223. PubMed ID: 30496435
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis.
Gu J; Wang S; Guo H; Tan Y; Liang Y; Feng A; Liu Q; Damodaran C; Zhang Z; Keller BB; Zhang C; Cai L
Cell Death Dis; 2018 Jan; 9(2):82. PubMed ID: 29362483
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
9. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
[TBL] [Abstract][Full Text] [Related]
10. Progress and challenges in understanding the regulation and function of p53 dynamics.
Yang Z; Hanson RL; Batchelor E
Biochem Soc Trans; 2021 Nov; 49(5):2123-2131. PubMed ID: 34495325
[TBL] [Abstract][Full Text] [Related]
11. circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cancer Sci; 2019 Feb; 110(2):568-581. PubMed ID: 30520539
[TBL] [Abstract][Full Text] [Related]
12. RBM10, a New Regulator of p53.
Jung JH; Lee H; Zeng SX; Lu H
Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
[TBL] [Abstract][Full Text] [Related]
13. Targeting LINC00673 expression triggers cellular senescence in lung cancer.
Roth A; Boulay K; Groß M; Polycarpou-Schwarz M; Mallette FA; Regnier M; Bida O; Ginsberg D; Warth A; Schnabel PA; Muley T; Meister M; Zabeck H; Hoffmann H; Diederichs S
RNA Biol; 2018; 15(12):1499-1511. PubMed ID: 30499379
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism.
Li L; Zeng H; He X; Chen JX
J Am Heart Assoc; 2021 Feb; 10(5):e018913. PubMed ID: 33586458
[TBL] [Abstract][Full Text] [Related]
15. Regulation and function of p53: A perspective from Drosophila studies.
Ingaramo MC; Sánchez JA; Dekanty A
Mech Dev; 2018 Dec; 154():82-90. PubMed ID: 29800619
[TBL] [Abstract][Full Text] [Related]
16. p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.
Nakamura H; Matoba S; Iwai-Kanai E; Kimata M; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Ariyoshi M; Mita Y; Ikeda K; Okigaki M; Adachi S; Tanaka H; Takamatsu T; Matsubara H
Circ Heart Fail; 2012 Jan; 5(1):106-15. PubMed ID: 22075967
[TBL] [Abstract][Full Text] [Related]
17. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
18. Senescence and aging: the critical roles of p53.
Rufini A; Tucci P; Celardo I; Melino G
Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
[TBL] [Abstract][Full Text] [Related]
19. Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway.
Wang G; Fu Y; Hu F; Lan J; Xu F; Yang X; Luo X; Wang J; Hu J
Cell Death Dis; 2017 Feb; 8(2):e2607. PubMed ID: 28182012
[TBL] [Abstract][Full Text] [Related]
20. miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.
Raut SK; Singh GB; Rastogi B; Saikia UN; Mittal A; Dogra N; Singh S; Prasad R; Khullar M
Mol Cell Biochem; 2016 Jun; 417(1-2):191-203. PubMed ID: 27221738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
